KannaLife Sciences, Inc. — Form D
KannaLife Sciences, Inc. of West Hills, NY, a company, filed a Form D exempt-offering notice with the SEC on 2012-02-03. The offering totals $15.0M. Industry: Pharmaceuticals.
Offering
- Filed: 2012-02-03
- Form: D
- Accession: 0001538856-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $15.0M
- Remaining: $15.0M
- Minimum investment: $10K
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-172861
Issuer
- Name: KannaLife Sciences, Inc.
- CIK: 0001538856
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 363 West Hills Road, West Hills, NY, 11743
- Phone: 516.669.3219
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| W. Dennis Drehkoff | Director | Oak Brook, IL |
| Thomas Dennis Kikis | Director | Flushing, NY |
| Ramesh Dennis Pandey | Director | Highland Park, NJ |
| W. Dennis Drehkoff | Executive Officer | Oak Brook, IL |
| Thomas Dennis Kikis | Executive Officer | Flushing, NY |
| Ramesh Dennis Pandey | Executive Officer | Highland Park, NJ |
| Dean Petkanas | Director | Lloyd Harbor, NY |
| Dean Petkanas | Executive Officer | Lloyd Harbor, NY |
| Mark Corrao | Executive Officer | Miramar, FL |
| Michael Mona, Jr. | Director | LAS VEGAS, NV |
| Stuart Titus | Director | Poway, CA |
| Thoma Kikis | Director | West Hills, NY |
| Thoma Kikis | Executive Officer | West Hills, NY |
Other filings by this issuer (1)
More